Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kinevant Sciences Gmbh

Clinical trials sponsored by Kinevant Sciences Gmbh, explained in plain language.

Drug trial aims to tame scarring lung disease

Disease control Terminated

This study tested whether a drug called namilumab could help control chronic pulmonary sarcoidosis, a disease that causes inflammation and scarring in the lungs. About 107 adults with this condition received either the drug or a placebo via injection every four weeks for six mont…

Phase: PHASE2 • Sponsor: Kinevant Sciences GmbH • Aim: Disease control

Last updated Feb 27, 2026 15:18 UTC